The ciliopathy Joubert syndrome is marked by cerebellar vermis hypoplasia, a phenotype for which the pathogenic mechanism is unclear 1-3 . To investigate Joubert syndrome pathogenesis, we have examined mice with mutated Ahi1, the first identified Joubert syndrome-associated gene 4, 5 . These mice show cerebellar hypoplasia with a vermis-midline fusion defect early in development. This defect is concomitant with expansion of the roof plate and is also evident in a mouse mutant for another Joubert syndrome-associated gene, Cep290 6, 7 . Furthermore, fetal magnetic resonance imaging (MRI) of human subjects with Joubert syndrome reveals a similar midline cleft, suggesting parallel pathogenic mechanisms. Previous evidence has suggested a role for Jouberin (Jbn), the protein encoded by Ahi1, in canonical Wnt signaling 8 . Consistent with this, we found decreased Wnt reporter activity at the site of hemisphere fusion in the developing cerebellum of Ahi1-mutant mice. This decrease was accompanied by reduced proliferation at the site of fusion. Finally, treatment with lithium, a Wnt pathway agonist 9 , partially rescued this phenotype. Our findings implicate a defect in Wnt signaling in the cerebellar midline phenotype seen in Joubert syndrome that can be overcome with Wnt stimulation.
Joubert syndrome is a developmental disorder marked by cerebellar vermis hypoplasia and a unique molar tooth sign on imaging (MTI) 2,3 , and it is part of a larger spectrum of disorders known as ciliopathies. Although the primary cilium seems to be involved in the pathogenesis of these disorders, its exact function within this context is not clear. Some hints have come from conditional mouse mutants of cilia proteins that show similar ciliopathy phenotypes, including cerebellar hypoplasia 10, 11 . However, the resulting cerebellar phenotypes appear more severe than those seen in Joubert syndrome, suggesting a more specific defect may be to blame in the human disease. Recent evidence has identified several key signaling pathways that are modulated by primary cilia, such as Wnt and Shh signaling 12, 13 . Because mouse mutants for genes mutated in Joubert syndrome have not yet been examined for cerebellar phenotypes, the mechanism of Joubert syndrome pathogenesis in cerebellar vermis formation is still not clear.
To study mechanisms of Joubert syndrome pathogenesis, we examined a mouse model of loss of function of Ahi1, which is mutated in Joubert syndrome 4, 5 . Adult Ahi1 −/− mice had a small body size as reported previously 14 , with slightly reduced brain size compared with Ahi1 +/− or Ahi1 +/+ mice, which were indistinguishable from each other (thus we used both genotypes interchangeably as controls; details are provided in the figures and figure legends). The overall brain morphology of Ahi1 −/− mice appeared normal except for a smaller cerebellum and underdeveloped vermis with a mildly defective foliation pattern 15 (Fig. 1a) . Vermian lobules VI and VII appeared fused, whereas lobule V appeared smaller and underdeveloped at 3 weeks of age. Overall, the cerebellum appeared slightly hypoplastic, suggesting a developmental defect that may be similar to Joubert syndrome, though much less severe in the mouse.
We next examined cresyl violet-stained midline sagittal sections, which revealed that although the overall brain size was reduced by 17% compared with controls ( Supplementary Fig. 1a ) the cerebellar vermis appeared more severely affected, as it was reduced by 40% ( Fig. 1b) , and this decrease was more statistically significant when corrected for total brain size, which decreased the variance (Supplementary Fig. 1a ). Foliation defects in lobules V, VI and VII were also visible on sagittal sections ( Fig. 1b) . Ahi1 −/− mice consistently had an average decrease of 1.5 in the number of folia compared with littermate controls (Fig. 1c) . Additionally, these size and foliation defects persisted beyond 3 weeks, throughout adulthood ( Supplementary Fig. 1b) .
Although MTI is present in humans with Joubert syndrome, there was no evidence of this sign in Ahi1 −/− mutants ( Supplementary  Fig. 1c ). Additionally, other defects described in Joubert syndrome, such as fragmentation of deep cerebellar nuclei and structural anomalies of the descending trigeminal tract and brainstem nuclei 16, 17 , were not evident in Ahi1 mutants ( Supplementary Fig. 1c,d) . Decussation of pyramidal axons, which can be abnormal in humans with Joubert syndrome 16, 17 , also appeared normal in Ahi1 mutants ( Supplementary Fig. 1e ). Furthermore, despite the cerebellar defects, cellular organization and layering appeared normal in Ahi1-mutant mice compared with littermate controls (Supplementary Fig. 2a ). Staining for the Purkinje neuron marker calbindin and the granule Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome neuron marker GABA-A receptor α6 revealed intact cell fate and layering ( Supplementary Fig. 2b ). Finally, Golgi-Cox stain revealed normal neuronal morphology within the adult cerebellum of mutant mice (Supplementary Fig. 2c ).
We next examined cerebellar development in Ahi1-mutant mice. At postnatal day five (P5), transverse sections revealed a vermal foliation defect with an overall smaller vermis in Ahi1 −/− mice ( Fig. 1d) . Similarly, sagittal sections at P4 revealed a smaller cerebellar vermis size and underdeveloped foliation, with lobules V, VI and VII most affected ( Fig. 1e) . At embryonic day 18.5 (E18.5), a very subtle size defect was evident, which was more pronounced at P4 (Fig. 1e,f) .
As both foliation and size are dependent upon expansion of cerebellar neurons, this phenotype could be due to defects in proliferation. We therefore tested BrdU staining in cerebellar granule neurons (CGNs) of the developing cerebellar midline. We examined several stages from E16.5 to P5 and detected a significant decrease in CGN BrdU staining within the vermis at E16.5, which recovered by E18.5 and remained equivalent at most postnatal time points, although a slight but significant decrease was evident at P5 ( Fig. 2a,b ). However, isolated P5 CGNs from Ahi1 −/− and control mice did not show a difference when labeled with BrdU in vitro (data not shown).
The proliferation defect at E16.5 could also be detected by phospho-histone H3 staining in vivo to detect cells in mitosis ( Supplementary Fig. 3a ). This suggests a relatively early defect in proliferation of CGN precursors. One of the major regulatory pathways in CGN proliferation is Shh signaling; however, this pathway is primarily active at postnatal time points 18 . But because cilia are required for mammalian Shh signaling, and Joubert syndrome is a ciliopathy, we nevertheless tested for a Shh defect in our mutant mice. We stained sections from P2 Ahi1 −/− and Ahi1 +/− littermates for N-myc, a proliferative gene target of Shh signaling. N-myc staining appeared strongest in CGNs, as reported previously 19 , and was not decreased in Ahi1 −/− cerebella ( Fig. 2c) . Furthermore, western blot analysis of N-myc protein abundance in whole cerebellum lysates at P3 revealed equal amounts in Ahi1 −/− mouse cerebellum compared with littermate control (Supplementary Fig. 3b ). We also stained for an independent Shh target, Patched (Ptch1), and observed similar levels of expression in Ahi1-mutant mice (Supplementary Fig. 3c ). Finally, we performed quantitative RT-PCR (qRT-PCR) for three Shh target gene mRNAs: N-Myc, Gli1 and Ptc1, and did not observe any differences in expression of the mRNAs in Ahi1 −/− mice compared with littermate controls (Fig. 2d) . Therefore, postnatal Shh signaling appears intact in Ahi1-mutant cerebella.
Given the early proliferation defect, we next examined the morphology of the developing cerebellum at earlier embryonic stages. Transverse sections from Ahi1 −/− embryos revealed a striking midline fusion defect at the cerebellar vermis primordium compared with control littermates (Fig. 3a) . This defect was most evident at E16.5, when control vermis had nearly completely fused whereas Ahi1 −/− vermis was thinner and malformed, and the defect was also clearly visible at E14.5 in Ahi1 −/− brain compared with control littermates (Fig. 3a) . Whole-mount images of embryos at E12.5 also revealed a separation of developing cerebellar hemispheres at the midline with expansion of the rhombic roof plate (Fig. 3b) .
To further examine this roof plate abnormality, we examined sagittal sections from an independent set of E12.5 embryonic brains. Serial midline and paramedial sections revealed a lengthened roof plate in Ahi1 −/− brain compared with littermate controls (Fig. 3c) . Furthermore, transverse sections at E13.5 revealed an overall widened roof plate in the Ahi1-mutant mice, as visualized by serial sections from anterior to posterior (Supplementary Fig. 4 ). Matched anterior sections at the site of cerebellar hemisphere fusion revealed defective fusion in Ahi1-mutant brain compared with control brains. These findings suggest the cerebellar phenotype may be a result of defective midline fusion with expansion of the roof plate, probably a secondary effect of incomplete growth of midline cerebellar tissue.
Because these studies were aimed at modeling Joubert syndrome, we tested whether our findings were also apparent in an alternate Joubert syndrome model: mice null for Cep290, the second gene to be identified in Joubert syndrome 6, 7 . Because the only published Cep290 mutant mouse is the rd16 line, an in-frame deletion without a cerebellum defect 20 , we decided to target Cep290 to completely inactivate the gene. We generated Cep290 −/− mice by targeted homologous recombination ( Supplementary Fig. 5a ). Although Cep290 has been described as a key cilia protein in other contexts 21 , Cep290 −/− mice appeared healthy overall with some runting and a retinal degeneration phenotype as in rd16 mice (data not shown). We nevertheless examined E16.5 Cep290 −/− mice for possible midline fusion defects. Similar to Ahi1 mutants, Cep290 −/− mice showed defective midline fusion at E16.5 that was slightly milder than the Ahi1-mutant phenotype ( Fig. 3d) . Additionally, adult Cep290 mutants showed a mild foliation defect, although the vermis was not statistically smaller than controls ( Supplementary Fig. 5b) .
To test whether an early midline fusion defect may be a precursor to Joubert syndrome in humans, we examined fetal MRI from human subjects later verified to have Joubert syndrome. In human development, cerebellar hemispheres fuse at the midline by 13 weeks gestational age to eventually develop into the vermis 22 . We were able to obtain MRIs from three subjects with Joubert syndrome between 21 and 25 weeks of gestational age, when fusion should be complete. However, fetuses with Joubert syndrome showed a striking separation of cerebellar hemispheres at the midline when compared to control fetuses ( Fig. 3e) . Furthermore, this defect was most severe on inferior axial images, where there was an apparent connection between the fourth ventricle and the cisterna magna. Similarly, in both Ahi1 −/− and Cep290 −/− mice, midline fusion appeared most defective on inferior (more posterior) transverse sections ( Fig. 3d and Supplementary  Fig. 5c ). Finally, 21-25 weeks gestational age in humans corresponds to a stage in cerebellar development after fusion occurs (13 weeks in humans, E13.5 in mice). Thus, although the human imaging is consistent with an early fusion defect, it may also be compatible with other early developmental defects leading up to the phenotype seen here. However, the similarities between the human and mouse phenotypes suggest these findings are consistent with an early fusion defect in humans with Joubert syndrome. We next tested the function of several AHI1 disease mutations to examine mechanisms of Joubert syndrome pathogenesis. We generated tagged plasmid-based expression constructs encoding Jbn with one of three disease-associated missense mutations: R723Q and H896R, in the WD40 domain, and V443D, adjacent to a putative atypical protein kinase C phosphorylation site 4, 23, 24 . These mutant proteins each showed comparable protein expression to wild-type Jbn in 293T cells (Supplementary Fig. 6a ) and mouse inner medullary collecting duct (IMCD) cells (Supplementary Fig. 6b ). We next examined localization and found that all three mutant proteins failed to localize to the primary cilium compared with wild-type Jbn (Supplementary Fig. 6c) .
As Jbn has been identified as a positive modulator of canonical Wnt signaling 8 , we next tested whether these disease mutation constructs were defective in modulation of Wnt activity. We performed luciferase assays with the Super Topflash Wnt reporter construct and treated cells with Wnt3A-conditioned medium. Overexpression of wild-type Jbn in these cells resulted in a 1.6-fold increase in reporter activity over vector control (Supplementary Fig. 7a) . In contrast, none of the mutants showed significantly increased Wnt activity compared with control ( Supplementary Fig. 7a) .
As we previously reported that Jbn interacts with β-catenin 8 , we tested the ability of GFP-tagged disease-associated mutant proteins to immunoprecipitate with β-catenin. This approach revealed an interaction between wild-type Jbn and β-catenin, as well as an interaction between the R723Q and H896R mutant proteins and β-catenin (Supplementary Fig. 7b ). However, the V443D mutant showed considerably less pulldown of endogenous β-catenin. Although soluble protein levels varied between the mutant and wild-type Jbn constructs, immunoprecipitation efficiencies were indistinguishable among the mutant proteins, indicating a specific reduction in interaction between β-catenin and the V443D protein. As Val443 is adjacent to a putative atypical protein kinase C phosphorylation site, this site may have a key role for β-catenin interaction.
We next tested whether Jbn localizes to cilia in CGNs. CGNs isolated from P5 wild-type mouse cerebella had cilia during the first 24 h after dissociation. Transfection with Jbn-GFP or staining for endogenous Jbn revealed localization to the basal body in CGNs ( Supplementary  Fig. 7c ). We additionally tested β-catenin colocalization by examining β-catenin-GFP and endogenous β-catenin, which showed colocalization with Jbn at the base of the cilium (Supplementary Fig. 7c) .
These findings point to a possible role for the primary cilium in Jbn's Wnt modulatory role. We therefore tested whether primary cilia were disrupted in Ahi1 −/− CGNs. CGNs isolated from Ahi1-null and control littermates were indistinguishable in their number of cilia and morphology (Supplementary Fig. 8a) , similar to the structurally normal cilia recently described in the kidney 8 and retina 14 of Ahi1 −/− mice. These results suggest that Jbn is not required for ciliogenesis but perhaps functions more specifically in ciliary-mediated signaling.
Several canonical Wnt-mutant mice show roof plate expansion and vermal defects [25] [26] [27] . Given Jbn's previously described role in modulating Wnt signaling, and our findings with the disease-associated mutant proteins, we tested whether Ahi1 −/− mice showed defective Wnt signaling. We crossed Ahi1 +/− mice to Wnt reporter BATgal transgenic mice 28 . We previously reported that Ahi1 and BATgal are genetically linked 8 . Therefore, to generate these mice, we backcrossed Ahi1 +/− BATgal + mice with Ahi1 +/− mice to recover mice with recombined alleles. As midline fusion begins at approximately E13. 5 (refs. 29,30) , we examined E13.5 Ahi1 −/− BATgal + embryos for Wnt defects compared with Ahi1 +/− BATgal + littermates. Whole-mount imaging revealed a decrease in Wnt signaling at the cerebellar midline anlage (Fig. 4a) . Further examination by transverse sectioning revealed a specific decrease in Wnt activity in cerebellar cells surrounding the midline in mutant tissue (Fig. 4a) . We also examined Shh signaling during midline fusion by staining for Gli1 and Ptc1. We observed very low-level expression of both factors, which appeared equally low in the Ahi1-mutant mice (Supplementary Fig. 8b) .
We next hypothesized that, as Wnt is a known mitogen, the tissue expansion at the midline may be due to a mitogenic role for Wnt signaling in this context. We examined proliferation of cerebellar precursors surrounding the site of fusion by BrdU pulse labeling. Control littermate embryos showed specific labeling of precursors immediately surrounding the fusion site, whereas Ahi1 −/− embryos had significantly fewer labeled cells in this region (Fig. 4b,c) . Furthermore, staining for Arl13b, a cilia marker, revealed a concentration of cilia at the site of fusion (Supplementary Fig. 8c ), suggesting Jbn's role may be crucial in these ciliated cells. However, cilia in Ahi1 −/− mice appeared indistinguishable from those of littermate controls (Supplementary Fig. 8c) , consistent with a role for Jbn in ciliary signaling rather than ciliogenesis.
We next performed a series of experiments using the Wnt agonist lithium to activate Wnt signaling 9 in Ahi1 −/− mice. We performed intraperitoneal injections of LiCl, or NaCl as a control, in pregnant dams 31 at E12.5 and then again at E13.5 and examined E14.5 morphology. We verified an increase in Wnt signaling with LiCl compared with those treated with NaCl (Supplementary Fig. 9a ). At E14.5, Ahi1 −/− embryos receiving NaCl showed midline fusion defects, as expected ( Fig. 4d) . However, Ahi1 +/− and Ahi1 −/− embryos that received LiCl were indistinguishable from each other, suggesting a rescue of the phenotype (Fig. 4d) . Notably, LiCl-treated embryos showed expanded cerebellar hemisphere tissue with less of a separation between hemispheres (Fig. 4d) , consistent with the hypothesis that canonical Wnt signaling promotes expansion of hemisphere tissue. However, fusion itself was not enhanced in embryos treated with LiCl, suggesting a separate regulatory mechanism for the specific process of midline fusion.
To quantify these effects, we measured the extent of midline fusion and proliferation in embryos treated with LiCl. We injected pregnant dams with LiCl at E12.5 and E13.5 and examined embryos at E14.5. We examined expansion of midline tissue by quantification of the size of the ventricular space between hemispheres from at least three mice of each genotype for each condition. This approach revealed a significantly larger interhemispheric space in untreated Ahi1 mutants compared with littermate control mice, whereas with lithium treatment there was no significant difference between mutants and controls (Fig. 4e) . To examine proliferation in these mice, we performed staining for Ki67, which revealed a significant decrease in the number of proliferating cells at the site of fusion of untreated Ahi1 −/− embryos compared with control littermates, whereas lithium treatment rescued this phenotype (Fig. 4f and Supplementary Fig. 9b) .
We next performed lithium treatments at E12.5 and E13.5 and examined morphology at later time points. At E16.5, midline morphology of treated Ahi1 −/− embryos was indistinguishable from that in control embryos, reflecting intact midline fusion, although the lateral aspect still appeared slightly reduced in size (Fig. 4d) . Furthermore, treated Ahi1-mutant mice examined at P4 showed a partial rescue of the size and foliation defects and more closely resembled control mice than did untreated mutant mice (Fig. 4g) . However, mutant mice still showed runting and early postnatal lethality, suggesting further treatment or other approaches may be needed to rescue this aspect of the phenotype. Finally, examination of Ahi1 mutant cerebella at P11 revealed slightly more complex foliation and increased size with lithium treatment compared with untreated mutant cerebella (Supplementary Fig. 9c) . Overall, we have examined five mutant mice at postnatal time points from P2 to P11 and have observed a partial rescue of cerebellar developmental defects in mice treated with lithium (data not shown).
We describe two animal models of Joubert syndrome that provide what is to our knowledge the first indication that the midline cerebellar hypoplasia seen in this disorder is due to a decrease in Wnt signaling, which can be rescued with lithium treatment. On the basis of our results with Ahi1-mutant mice, we propose a model of the events that occur during midline fusion, which are disrupted in Joubert syndrome (Supplementary Fig. 10a ). Midline fusion from E12.5 to E16.5 occurs with tissue growth at the midline that progressively fills in both posteriorly and ventrally. Rescue experiments with lithium treatments suggest that vermis formation may reflect a combination of at least two processes. First, the surrounding tissue expands as a result of Wnt-dependent proliferation. Second, the two adjacent cerebellar hemispheres appear to adjoin and later fuse at the midline through an as-yet undefined process, which probably involves cell migration and cell intercalation. Wnt pathway mutations have been identified in cerebellar cancer, termed medulloblastoma 32 , but an endogenous role for Wnt signaling in cerebellar precursor proliferation has not previously been identified. The early Wnt-dependent proliferation at the midline described here is at least one key step that is abnormal in mouse models of Joubert syndrome. This proliferation defect can be mathematically modeled using our observations from BrdU pulse labeling experiments, which reveals a fit with a two-stage model of proliferation during cerebellar development: an early Wnt-dependent stage and a later Shh-dependent stage (Supplementary Fig. 10b and  Supplementary Discussion) .
The Ahi1-mutant and Cep290-mutant phenotypes are relatively mild in comparison to phenotypes arising from mutation of genes required for ciliogenesis 10, 11 . This, along with the cilia staining in Ahi1-mutant mice, suggests that Joubert syndrome may reflect a more specific defect in cilia function or signaling rather than an overall ciliogenesis defect. Both Jbn and Cep290 have been implicated in transport at the cilium 14, 33, 34 , and Jbn has already been shown to function in nuclear β-catenin transport 8 . Perhaps deficient transport of signaling components such as β-catenin is responsible for more specific downstream signaling defects. Additionally, although Shh signaling appeared largely intact in our mutant mice, we cannot rule out possible roles of other signaling pathways involved in cerebellum development, such as the bone morphogenetic protein 35 , Notch 32 and fibroblast growth factor 36 signaling pathways, and it will be useful to examine possible roles for the cilium in these pathways. Overall, these results provide insight into a precise mechanism of Joubert syndrome pathogenesis and a unique process of midline fusion involving proliferation followed by tissue fusion at the midline. We propose that it is the proliferative phase that is defective in Joubert syndrome and leads to hypoplasia of the cerebellar vermis. Future studies, as well as more complete evaluations, will be needed to test whether Wnt pathway modulators, such as lithium, may be promising candidates for treatment of Joubert syndrome.
MeThOds
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
ONLINe MeThOds
Plasmid constructs and materials. We generated disease-associated mutation constructs using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The β-catenin-GFP construct was obtained from K. Willert, and Jbn-GFP was used as previously described 8 . We obtained Wnt3a-conditioned medium from L cells stably transfected with a Wnt3a expression construct as previously described 8 .
Generation of mouse lines. Ahi1 −/− mice were described previously and we crossed heterozygotes to BATgal + mice (kindly provided by S. Piccolo) 28 . We generated Cep290-null mice by targeted homologous recombination to generate a conditional allele (loxP-flanked, 'flox'). The floxed region (containing exons 36 and 37 of 52 exons) and flanking homology arms of Cep290 were PCR-amplified from 129/SvJ genomic DNA, flanked with SalI, BamHI and XhoI restriction sites and subcloned into the modified pflox vector 37 (from J. Marth) containing PGKneobpA (positive selection) and HSV-TK (negative selection). This was linearized with SbfI and transfected into 129SvJ-derived ES cells. We selected G418and gancyclovir-resistant clones and injected these into C57Bl/6 blastocysts. High-percentage chimeras were bred to C57BL/6 mice for germline transmission and to EIIa-Cre mice to generate mosaic Cre recombinants, which were bred to C57BL/6 to isolate mice with null alleles. We confirmed null mice to lack Cep290 protein (data not shown). We genotyped mice by PCR in two reactions, one amplifying a 370-bp (null allele) and the other a 414-bp (wild-type) product. The null allele primers were Cep290KO-F1: 5′-GGCTCACTGTGATCTTGTGC-3′ and Cep290KO-R2: 5′-TGGAAGACCAGGCTTCAGAG-3′, and the wildtype primers were Cep290WT-F2: 5′-GTAAGTGCCCGACAGCTACC-3′ and Cep290WT-R2: 5′-AGCGCAGTGCAGAGTATGTG-3′. Mouse work was carried out in compliance with UCSD Institutional Animal Care and Use Committee-approved protocols. Mice of both sexes were used.
Research subjects. Brain MRI analysis was completed during the clinical assessment of pregnancies at risk for developing Joubert syndrome (on the basis of previously affected older siblings with clinically and radiologically proven Joubert syndrome) by standard sequence protocols at Cairo University (MRI unit in Kasr Al-Ainy Hospital) 38 . One representative MRI at 25 weeks of gestational age from a subject later confirmed to have Joubert syndrome is provided as well as a control MRI at 25 weeks of gestational age. We obtained parental written informed consent from all families, and the study was approved by the Human Research Protection Program Committees of UCSD (La Jolla) and Cairo University (Egypt).
Histology and immunohistochemistry. We obtained brain sections by perfusion fixation followed by embedding in 10% wt/vol gelatin, 7.5% wt/vol sucrose and cryosectioning at 20 µm thickness. We stained sections with cresyl violet and imaged for morphology. Size measurements were performed in a blinded manner using ImageJ to find edges and quantify area from midline (for cerebellar vermis size) and paramedial (for total brain size) sections of each of three mice for each genotype: Ahi1 −/− , Cep290 −/− or littermate controls. We quantified foliation by counting the number of lobules as designated by complete separation with intervening molecular layer. We performed X-gal staining identically between control and mutant tissues as previously described for 1-3 h on whole mounts or sections 8 . We stained littermates in parallel in the same X-gal solution. We performed BrdU labeling by injecting pregnant dams or neonatal pups intraperitoneally with 100 µg per g body weight of BrdU from a stock solution of 10 mg ml −1 in normal saline. We dissected brains and fixed them for 1 h after BrdU injection. Cells labeled with BrdU or Ki67 were counted from images identically acquired and counted in a blinded manner. We performed intraperitoneal injections of equimolar LiCl or NaCl (10 µl of a 600 mM stock solution in normal saline per gram body weight 31 ) in timed pregnant dams at E12.5 and again at E13.5. For Golgi-Cox staining, we used the FD Rapid GolgiStain kit (FD NeuroTechnologies) according to the manufacturer's instructions.
We carried out immunostaining of sections or isolated cells by blocking in 4% vol/vol donkey serum in 0.1% vol/vol Triton X, followed by staining with the following primary antibodies: mouse antibody to acetylated tubulin (Zymed, 32-2700, 1 in 500 dilution), rabbit antibody to Jbn 8 (1 in 500), rabbit antibody to β-catenin (Cell Signaling, 95825, 1 in 200), rat antibody to BrdU (Abcam, ab6326, 1 in 200), rat antibody to N-myc (Cell Signaling, 9405, 1 in 200), chicken antibody to β-galactosidase (Abcam, ab9361, 1 in 250), rabbit antibody to calbindin (Swant, D28K, 1 in 250), rabbit antibody to GABA-A receptor α6 (Chemicon, AB5610, 1 in 500), rat antibody to Ptc1 (R&D systems, MAB41051, 1 in 100), rabbit antibody to Gli1 (Chemicon, AB3444, 1 in 200), rabbit antibody to Arl13b (1 in 1,500, gift from T. Caspary), rabbit antibody to Ki67 (1 in 200, Novocastra, NCL-Ki67p), and rabbit antibody to PH3 (Upstate, 06-570, 1 in 200). For Jbn staining, we performed antigen retrieval by heating samples in 100 mM Tris, 5% urea, pH 9.5 at 95 °C for 10 min. Samples were then washed in PBS and stained with the following secondary antibodies: Alexa Fluor donkey antibody to mouse 594, donkey antibody to rat 488, donkey antibody to rabbit 488, goat antibody to rabbit 350 (all Molecular Probes, 1 in 500). Hoechst (Molecular Probes, H3570) was used as the nuclear stain. We isolated CGNs according to a previously published protocol 39 and fixed in 4% wt/vol paraformalehyde 5 h after plating onto poly-d-lysine-coated slides followed by washing, blocking and staining. We performed transfection of CGNs with GFP constructs using Amaxa nucleofector primary neuron kit according to the manufacturer's protocol. We carried out transfection of Jbn disease mutation GFP constructs in IMCD cells using Lipofectamine 2000 (Invitrogen) according the manufacturer's guidelines. We acquired and quantified images using a DeltaVision Spectris deconvolution or a FV1000 Spectral Deconvolution Confocal microscope (UCSD Neuroscience Microscopy Core).
Western blotting and luciferase. We performed western blotting on lysates prepared in modified RIPA buffer using the following antibodies: rabbit antibody to N-myc (Cell Signaling, 9405), mouse antibody to β-catenin (BD Transduction Labs, 610153), goat antibody to glyceraldehyde 3-phosphate dehydrogenase (Santa Cruz, SC-20357), mouse antibody to GFP (Covance, B34), rabbit antibody to TFIIH (Santa Cruz, SC-293) and mouse antibody to α-tubulin (Sigma, T-6074). All antibodies were used at 1 in 1,000 dilution. Rabbit antibody to GFP (Genetex, Gtx26556, 1 µg) was used for immunoprecipitations from modified RIPA lysates using protein A-Sepharose beads (GE Healthcare). For transient transfections of fibroblasts or IMCD cells, we used Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. For luciferase assays, we grew fibroblasts in 12-well plates and transfected with 600 ng Super Topflash, 120 ng β-galactosidase and 650 ng of Jbn expression plasmids, empty vector or disease mutation construct (all containing GFP that we mutated at Y66G to disrupt fluorescence and avoid cross activity with luminescence, using QuikChange mutagenesis). Twenty-four hours after transfection, cells were serum starved for 8 h and then treated overnight with Wnt3a-conditioned medium diluted 3:1 in serum-free medium. We performed the luciferase assay as previously published 8 , and we measured β-galactosidase activity using the Tropix Galacto-light Plus kit (Applied Biosystems, T1007).
Quantitative RT-PCR. We isolated cerebella from three mice of each genotype, Ahi1 −/− and littermate controls, at P1, and we extracted RNA using Trizol reagent (Invitrogen). This was used to make cDNA using Superscript III (Invitrogen) according to the manufacturer's directions. We performed quantitative PCR in triplicate for each sample and assayed each gene with LightCycler 480 Sybr Green (Roche). We performed analysis using instrument software to obtain crossing point values. Averages were then normalized to values for actin. For statistical analyses, Student's t test was performed to compare knockout to littermate control values for all quantitative assays. Error bars are s.e.m.
Biotinylated dextran amine tracing assay. We stereotactically injected the anterograde tracer biotinylated dextran amine into layer V of the right sensorimotor cortex of adult Ahi1 +/+ and Ahi1 −/− mice (n = 2 per genotype) following previously established methods 40 . We then killed the mice 3 weeks later and prepared 20-µm cryosections, which we stained with 3,3′-diaminobenzidine to visualize labeled corticospinal tract fibers.
